Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Patients With Open-angle Glaucoma or Ocular Hypertension

NCT05181046 is registered in ClinicalTrials.gov with Nanodropper, Inc. as lead sponsor.

NCT NCT05181046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05181046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Patients With Open-angle Glaucoma or Ocular Hypertension
Lead sponsor
Nanodropper, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 6, 2021
Completion date
December 19, 2022
Enrollment
420 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, glaucoma and ocular hypertension, glaucoma, open-angle, glaucoma, primary open angle, ocular hypertension